Clinical Trials on Relapsed/Refractory Sarcomas in Germany

Total 2736 results

Profil Institut für Stoffwechselforschung GmbH
Pendragon Medical AG Switzerland

Completed

Changes in Serum Electrolytes at Different Glucose Concentrations + Impact on a Non-invasive Glucose Monitoring Method

Diabetes Mellitus

Germany
West German Center of Diabetes and Health
Bionatural GmbH

Completed

Foot Cream for the Care of Dry and Cracked Skin

Diabetes Mellitus

Germany
RSP Systems A/S

Completed

A Study of a Non-invasive Glucose Measuring Device in Out-patient Settings

Diabetes Mellitus

Germany
RSP Systems A/S

Completed

Study of a Non-invasive Glucose Measuring Device

Diabetes Mellitus

Germany
Galderma R&D

Completed

Comparison Dry Foot Skin Between Diabetic and Non-diabetic Subjects and the Effects of Two Cosmetic Foot Care Products

Xerosis Cutis

Germany
Julphar Gulf Pharmaceutical Industries
Profil Institut für Stoffwechselforschung GmbH

Completed

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal

Diabetes Mellitus

Germany
Bayer

Completed

Association Between the Prevalence of Cardiovascular Risk Factors and New Use of Testosterone

Hypogonadism

Germany
Novo Nordisk A/S

Completed

Within-subject Variability of Insulin Detemir in Healthy Volunteers

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspart (FIAsp) After Different Injection Regions and Routes of Administration in Healthy Subjects

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Safety and Tolerability of NN9068 in Healthy Male Volunteers

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

A Trial Comparing the Effect of NN1250 After Different Routes of Injection in Healthy Subjects

Healthy | Diabetes

Germany
Julphar Gulf Pharmaceutical Industries
Profil Institut für Stoffwechselforschung GmbH

Completed

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III

Diabetes Mellitus

Germany
Novo Nordisk A/S

Completed

Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese Subjects

Healthy | Diabetes

Germany
Julphar Gulf Pharmaceutical Industries
Parexel; Profil Institut für Stoffwechselforschung GmbH

Completed

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics of Julphar Insulin R and Huminsulin® Normal

Diabetes Mellitus

Germany
Novo Nordisk A/S

Completed

Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

A Trial Investigating the Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in a Tablet Formulation With Three Different Coatings in Healthy Subjects

Healthy | Diabetes

Germany
Heidelberg University

Completed

Postoperative Hyperthyroidism

Hyperthyroidism

Germany
Profil Institut für Stoffwechselforschung GmbH
Novo Nordisk A/S

Completed

Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses

Diabetes Mellitus

Germany
University Hospital Muenster

Completed

Safety of Testosterone Undecanoate i.m. in Hypogonadal Men

Hypogonadism

Germany
Central Institute of Mental Health, Mannheim

Not yet recruiting

Increasing Smoking Cessation Success Through Sleep-amplified Memory Consolidation

Tobacco Use Disorder

Germany
ARCIM Institute Academic Research in Complementary...

Completed

Resilience Training for Work-related Stress in Employees and the Influence of the Lecture Format on Training Success

Burnout | Work-Related Stress

Germany
University Hospital, Bonn

Completed

Directional Spread in Geographic Atrophy (DSGA)

Nonexudative Age-related Macular Degeneration

Germany
Myocardial Solutions

Completed

MyoStrain CMR for the Detection of Cardiotoxicity (Prefect)

Heart Failure | Cardiotoxicity | Chemotherapeutic Toxicity

Germany
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Completed

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Clear Cell Renal Cell Carcinoma | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Recurrent Adult Lymphoblastic Lymphoma | Untreated Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia in Remission | Childhood Acute... and other conditions

United States, Germany, Italy
University of Cologne

Completed

Study on the Reduction of Catheter-related Infections by Use of Self-disinfecting Venous and Arterial Access Caps (STERILE)

CLABSI - Central Line Associated Bloodstream Infection | Catheter-Related Blood Stream Infection

Germany
Sanofi

Completed

A Drug-Drug Interaction Study Between Sotagliflozin and Ramipril

Diabetes Mellitus | Healthy Subjects

Germany
Novo Nordisk A/S

Completed

Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Bioequivalence of Two Mixtard® 30 Formulations in Healthy Subjects

Healthy | Diabetes

Germany
Becton, Dickinson and Company

Completed

Multi-day (3) In-patient Evaluation of Intradermal Versus Subcutaneous Basal and Bolus Insulin Infusion

Diabetes

Germany
Sanofi

Completed

LISA-study : Levothyroxin in Nodular Goiter

Goiter, Nodular

Germany
GWT-TUD GmbH
Hoffmann-La Roche

Recruiting

Polatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in Second Line Treatment of Diffuse Large B-cell Lymphoma (DLBCL) (Pola-R-ICE)

Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-cell Lymphoma

Germany, Spain, United Kingdom, Austria
IlDong Pharmaceutical Co Ltd

Recruiting

IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics

Type 2 Diabetes

Germany
Boehringer Ingelheim
Eli Lilly and Company

Completed

Characteristics of Empagliflozin Initiators

Type 2 Diabetes

Germany
University Hospital, Bonn

Withdrawn

Deep Brain Stimulation (DBS) for Treatment Resistant Bipolar Disorder (DBS-BIPO)

Bipolar Disorder

Germany
Novo Nordisk A/S

Completed

A Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic Profiles

Diabetes

Germany
medac GmbH

Recruiting

Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy (IDUNN)

Steroid-refractory Acute Graft-versus-host Disease

Spain, Germany, France, Poland, Sweden
Hoffmann-La Roche

Completed

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Sarcoma

Spain, Belgium, Canada, Czechia, France, Brazil, United Kingdom, Israel, Italy, Russian Federation, Netherlands, Poland, Chile, Germany
Dr. Frank Behrens
Bionorica SE

Active, not recruiting

Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo (SILVER)

Drug-induced Liver Injury

Germany
Kite, A Gilead Company

Active, not recruiting

Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (ZUMA-7)

Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

United States, Spain, United Kingdom, Canada, Netherlands, Germany, France, Sweden, Israel, Switzerland, Belgium, Australia, Austria, Italy
German Diabetes Center

Completed

Impact of Branched-chain Amino Acids in the Development of Insulin Resistance (BRAAWO)

Diabetes

Germany
Charite University, Berlin, Germany

Unknown

FGF-21 and Exercise in Relation to Insulin Secretion

Physical Activity

Germany
Novo Nordisk A/S

Completed

A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy Subjects

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Subjects

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Bioequivalence of Two Insulatard® Formulations in Healthy Subjects

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of Semaglutide

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes

Healthy | Diabetes

Germany
Diurnal Limited
Treatment of Adrenal Insufficiency in Neonates consortium (TAIN)

Completed

Treatment of Adrenal Insufficiency in Children

Adrenal Insufficiency

Germany
Novo Nordisk A/S

Completed

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Subjects

Healthy | Diabetes

Germany

3

Subscribe